Keywords: Watson Pharma, Ascent Pharmahealth, M&A, Australia, Southeast Asia, 2011 results

Watson buys Strides Arcolab unit for A$375 million; 2011 results

Article | 24 January 2012

Print This

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has kicked off the new year with the acquisition of Ascent Pharmahealth, the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in